Navigation and service

Use of cookies

By clicking on "Allow" you consent to the anonymous recording of your stay on the site. The evaluations do not contain any personal data and are used exclusively for the analysis, maintenance and improvement of our website. For further information on data privacy, please click on the following link: Data Privacy Policy

OK

Seroepidemiological study on the spread of SARS-CoV-2 in Germany: Study protocol of the ‘CORONA-MONITORING bundesweit’ study (RKI-SOEP study) – Journal of Health Monitoring S1/2021

Abstract: The SARS-CoV-2 coronavirus has spread rapidly across Germany. Infections are likely to be under-recorded in the notification data from local health authorities on laboratory-confirmed cases since SARS-CoV-2 infections can proceed with few symptoms and then often remain undetected. Seroepidemiological studies allow the estimation of the proportion in the population that has been infected with SARS-CoV-2 (seroprevalence) as well as the extent of undetected infections. The ‘CORONA-MONITORING bundesweit’ study (RKI-SOEP study) collects biospecimens and interview data in a nationwide population sample drawn from the German Socio-Economic Panel (SOEP).

Participants are sent materials to self-collect a dry blood sample of capillary blood from their finger and a swab sample from their mouth and nose, as well as a questionnaire. The samples returned are tested for SARS-CoV-2 IgG antibodies and SARS-CoV-2 RNA to identify past or present infections.

The methods applied enable the identification of SARS-CoV-2 infections, including those that previously went undetected. In addition, by linking the data collected with available SOEP data, the study has the potential to investigate social and health-related differences in infection status. Thus, the study contributes to an improved understanding of the extent of the epidemic in Germany, as well as identification of target groups for infection protection.

Date of issue March 25, 2021 PDF (3 MB, File does meet accessibility standards.)